Solanine Attenuates Hepatocarcinoma Migration and Invasion Induced by Acetylcholine
Overview
Pharmacology
Affiliations
Aim: Evidence has provided an explanation of the correlation between the nervous system and the tumor microenvironment. Neurotransmitters may be involved in different aspects of cancer progression. The glycoalkaloid solanine has been reported to suppress neural signaling pathways and exists in numerous plants, including , which have been demonstrated to inhibit cancer cell proliferation.
Methods: We evaluated the potentials of solanine on inhibiting acetylcholine-induced cell proliferation and migration in hepatocellular carcinoma cells.
Results: The results indicated that solanine markedly attenuated cell proliferation and migration via inhibiting epithelial-mesenchymal transition and matrix metalloproteinases in acetylcholine-treated Hep G2 cells. In addition, exosomes derived from acetylcholine-treated Hep G2 cells were isolated, and solanine showed inhibiting effects of extrahepatic metastasis on blocking cell proliferation in exosome-treated A549 lung carcinoma cells through regulating microRNA-21 expression.
Conclusion: Solanine has strong potential for application in integrative cancer therapy.
Nandi S, Sikder R, Nag A, Khatua S, Sen S, Chakraborty N Food Sci Nutr. 2024; 12(10):7088-7107.
PMID: 39479710 PMC: 11521658. DOI: 10.1002/fsn3.4221.
Active components of Solanum nigrum and their antitumor effects: a literature review.
Zhang H, Lv J, Zheng Q, Li J Front Oncol. 2024; 13:1329957.
PMID: 38192621 PMC: 10773844. DOI: 10.3389/fonc.2023.1329957.
Egbuna C, Patrick-Iwuanyanwu K, Onyeike E, Uche C, Ogoke U, Riaz M Food Sci Nutr. 2023; 11(7):4155-4169.
PMID: 37457177 PMC: 10345731. DOI: 10.1002/fsn3.3405.
The Therapeutic Value of Solanum Steroidal (Glyco)Alkaloids: A 10-Year Comprehensive Review.
Delbrouck J, Desgagne M, Comeau C, Bouarab K, Malouin F, Boudreault P Molecules. 2023; 28(13).
PMID: 37446619 PMC: 10343844. DOI: 10.3390/molecules28134957.
Tang X, Guo Y, Zhang S, Wang X, Teng Y, Jin Q Drug Des Devel Ther. 2023; 17:389-402.
PMID: 36789094 PMC: 9922515. DOI: 10.2147/DDDT.S389764.